Biotechnology/Chemical/Pharmaceutical Customer Partnership

Tuesday, March 6, 2012
9:30 AM to 4:00 PM
United States Patent and Trademark Office
Alexandria, Virginia

Madison Auditorium
600 Dulany Street, Alexandria, VA

The most recent quarterly meeting for the Biotechnology and Chemical Pharmaceutical Customer Partnership was held on December 1, 2011 at the U.S. Patent and Trademark Office. The Biotechnology and Chemical Pharmaceutical Customer Partnership is designed and developed to be a forum to share ideas, experiences, and insights between individual users and the USPTO. The USPTO does not intend to use these customer partnership groups to arrive at any consensus. Invitations to participate will indicate that individual opinions are sought, rather than a group consensus and that the meetings are intended to be informal in nature and have varying participants. These customer partnership groups are formed with full recognition of the USPTO's responsibility under the Federal Advisory Committee Act (FACA), and that these customer partnership groups are not established as FACA compliant committees.

We value our customers in obtaining feedback from individual participants is important in our efforts to continuously improve the quality of our products and services. Your willing participation is helpful in providing us with insights and experiences in this informal process to assist us.

The next meeting of the U.S. Patent and Trademark Office Biotechnology and Chemical Pharmaceutical Customer Partnership is scheduled for Tuesday, March 6, 2012 from 9:30 AM to 4:00 PM at Auditorium in Madison East, 600 Dulany Street, Alexandria, Virginia.

For information of future meetings and presentations, please go to http://www.cabic.com/bcp/.

Please contact Cecilia Tsang at 571-272-0562, or by fax at 571-273-0562, or email Cecilia.Tsang@uspto.gov to decline or confirm your attendance by February 27, 2011.

 

 

Request for Comments and Notice of Public Hearings on Genetic Diagnostic Testing

The USPTO is presently conducting the Genetic Testing Study required under the America Invents Act. A Federal Register Notice (hyperlink below) was published on January 25, 2012 to announce public hearings and seeking written comments for the study. Your organizations might consider participating as the agency benefits greatly from public input.

The specific topics for study are listed in the notice. The hearing dates are below, and the written comment period closes on March 26, 2012.

  • Thursday, February 16 at the USPTO Campus in Alexandria, Virginia from 9 AM to 4 PM
  • Friday, March 9 at the Joan B. Kroc Institute for Peace & Justice, University of San Diego, San Diego, California from 9 AM to 4 PM

Federal Register- Request for Comments and Notice of Public Hearings on Genetic Diagnostic Testing

 

Agenda & Schedule - Biotechnology/Chemical/Pharmaceutical Customer Partnership Meeting

Morning Session
9:30 - 9:45 Opening Remarks George Elliott, Wanda Walker and Dan Sullivan (Acting), Directors, TC1600
9:45 - 10:45 Lead Compound CAFC Obviousness Analysis Joseph Mallon, Partner, Knobbe Martens Olson & Bear LLP

10:45 -11:00

Break  
11:00 - Noon Native American Herbal Medicines Patricia Leith, Primary Examiner, Art Unit 1655
12:00 - 1:00 Lunch
Afternoon Session
1:00 - 2:30 Introduction to Examiners' Training and Attorney's Perspective Kathleen Bragdon, QAS, TC1600
2:30 - 2:45 Break  
2:45 - 3:45 NPRM - Changes to Implement the Inventor's Oath or Declaration Provisions of the Leahy-Smith America Invents Act Michele Cimbala, Ph.D
Sterne Kessler Goldstein Fox
3:45 - 4:00 Closing Remarks/Discussion George Elliott, Wanda Walker and Dan Sullivan (Acting), Directors, TC1600

 

Accessing the event online

Instructions for the Public

(on-campus participants are expected to attend the live event in person)

1. Double click on the link below (or copy it into your Internet Browser)

https://uspto.connectsolutions.com/r80345544/

2. Use the "Enter as a Guest" option.
2. Sign-in using your first and last name.
3. Click on the "Enter Room" button.
4. You will be admitted to the meeting.

Assistance

If you need assistance with login or if there is a problem with the webcast, please contact the OCIO Service Desk at 571-272-9000.

 

Instructions for Teleworkers

Detailed access instructions are as follows:

Completely log out of your RDP session (does not apply to ULP users) and sign out
of your VPN session. Once out of the VPN, paste the URL link into your local browser.
You can do this by following the detailed instructions below:

1. Select and copy or write down the above URL link for the Adobe Connect session or leave
the associated e-mail in your Inbox (email can only be accessed using web mail - https://email.uspto.gov ).

2. Save all open files on your desktop. Files can remain open.

*** (ULP users, skip to step 4)***

3. Disconnect from your RDP session.
Start > Disconnect
4. Exit MCS (if applicable).
5. Disconnect from the VPN - There are 2 options to disconnect from the VPN.

Option 1 - In the top right corner of the Enterprise Remote Access - Client Application
Sessions Internet Explorer window, click "Sign Out".

Option 2 - To the left of the system clock in the system tray, right click the golden padlock icon and left click "Sign Out".


6. You are now ready to access the live event via Adobe Connect

 

Accessing Adobe Connect to view Webcast

Accessing Adobe Connect to view Webcast

1. Paste or type the link below (same as above) into your Internet browser.

https://uspto.connectsolutions.com/r80345544/

2. Use the "Enter as a Guest" option.
3. Sign-in using your first and last name.
4. Click on the "Enter Room" button.
5. You will be admitted to the meeting.

Assistance

If you need assistance with login or if there is a problem with the webcast, please contact the OCIO Service Desk at 571-272-9000.